Tom Miller
FounderFounder at Iambic Therapeutics, Inc. · Co-Founder & CEO at Iambic
San Diego, California, United States
About
Tom Miller, Ph.D., co-founded Iambic Therapeutics in 2020 and serves as its CEO, working at the intersection of AI, chemistry, and biology. Before Iambic, he spent over 10 years as a professor at the California Institute of Technology, where he received tenure and published more than 140 peer-reviewed articles and patents. Miller holds a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford, and he serves as an independent director at Veracyte (Nasdaq: VCYT).
Founder at Iambic Therapeutics, Inc.
Intro paths
→
In turn, Tom can intro founders to Iambic Therapeutics, Inc.'s investors below.
Iambic Therapeutics, Inc.'s investors · 3
Co-founders at Iambic Therapeutics, Inc.
FM
Fred ManbyExecutive Officer, Director
Co-Founder & CEO at Iambic
Intro paths
→
In turn, Tom can intro founders to Iambic's investors below.
Iambic's investors · 11
AbingworthLondon · $15M – $30M checksAlumni VenturesManchester · $100K – $10M checksAscenta CapitalWilmingtonCatalio Capital ManagementNew YorkCatalio Capital Management, LPNew YorkCoatue ManagementNew York · $1M – $20M checksEisai Innovation, Inc.San FranciscoFREEFLOWBerkeleyIllumina VenturesFoster CityNVIDIASanta Clara · since 2024OrbiMedNew York · $1M – $75M checks
Co-founders at Iambic
FM
Fred ManbyCo-Founder & CTO
TM.jpg)
Thomas MillerFounder
Founder at Iambic
Intro paths
→
In turn, Tom can intro founders to Iambic's investors below.
Iambic's investors · 11
AbingworthLondon · $15M – $30M checksAlumni VenturesManchester · $100K – $10M checksAscenta CapitalWilmingtonCatalio Capital ManagementNew YorkCatalio Capital Management, LPNew YorkCoatue ManagementNew York · $1M – $20M checksEisai Innovation, Inc.San FranciscoFREEFLOWBerkeleyIllumina VenturesFoster CityNVIDIASanta Clara · since 2024OrbiMedNew York · $1M – $75M checks
Co-founders at Iambic
TM
Tom MillerCo-Founder & CEO
FM
Fred ManbyCo-Founder & CTO
Experience
- Iambic TherapeuticsCo-founder and CEOcurrent2020 — presentLa Jolla, California, United States
- Veracyte, Inc.Member Board of Directorscurrent2024 — present
- California Institute of TechnologyProfessor of Chemistry2013 — 2022
- California Institute of TechnologyAssistant Professor2008 — 2013
- UC BerkeleyPostdoctoral Fellow2005 — 2008
Skills & more
Spectroscopy32Physical Chemistry40Computational Chemistry27Molecular Dynamics20Quantum Chemistry20Nanotechnology19Theoretical Chemistry9Chemistry34High Performance Computing5molecular modeling7Scientific Computing18Monte Carlo Simulation7
+8 more
Statistical MechanicsBiophysicsNanomaterialsMolecular ModelingSimulationsResearchSciencePhysicsFrom Tom's professional profile.
Frequently asked questions
- Who is Tom Miller?
- Tom Miller, Ph.D., co-founded Iambic Therapeutics in 2020 and serves as its CEO, working at the intersection of AI, chemistry, and biology. Before Iambic, he spent over 10 years as a professor at the California Institute of Technology, where he received tenure and published more than 140 peer-reviewed articles and patents. Miller holds a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford, and he serves as an independent director at Veracyte (Nasdaq: VCYT).
- Where does Tom Miller work?
- Tom Miller is Co-Founder & CEO of Iambic and Co-founder at Iambic Therapeutics, Inc..
- What companies did Tom Miller found?
- Tom Miller founded Iambic, Iambic Therapeutics, Inc..
- Where did Tom Miller go to school?
- Tom Miller studied at University of Oxford (Doctor of Philosophy (Ph.D.), Theoretical Chemistry); UCL (Master of Philosophy (M.Phil.), Theoretical Chemistry); Texas A&M University (Bachelor of Science (B.S.), Chemistry and Mathematics).
Same school
Also attended University of Oxford1,334
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 1,328 more
Also attended UCL558
Demis HassabisCo-founder & CEO of Google DeepMindAndré DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone
+ 552 more
Also attended Texas A&M University197
Kanu GulatiInvestor at Khosla VenturesNathaniel HardingManaging Partner at Cortado VenturesJackie PfisterChief Operating Officer at Mercury FundLisa RobertsChief Product Officer at Mercury FundBrent KeltonPartner & Texas Leader at Moneta VenturesClinton BybeeCo-founder & Managing Director, Emeritus at ARCH Venture Partners
+ 191 more
Shared employers
Also worked at Iambic Therapeutics4
Also worked at Veracyte, Inc.4
.png)
Also worked at California Institute of Technology91
Alex BlaniaCo-founder & CEO of Tools for HumanityHaomiao HuangFounding Partner at Matter Venture PartnersConnor CooleyVenture Partner at Electric Feel Ventures LlcHelen McBrideOperating Partner at BOLD LongevityAlex HartzGeneral Partner at Shine CapitalIlya FushmanPartner at KPCB
+ 85 more
Also worked at UC Berkeley356
Ali GhodsiCo-founder & CEO of DatabricksRaquel UrtasunFounder & CEO of WaabiArhaan A.Deeptech Fellow at Clear VenturesKevin Wijayaインドネシア法人代表 (Indonesia Office Representative) at CyberAgent CapitalPaul JennyBoard Chair at CincyTechAndrea van ElsasInvestor at Third Rock Ventures
+ 350 more